Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Geron Corporation
About GERN
Geron Corporation is a commercial-stage biopharmaceutical company. The Company develops first-in-class telomerase inhibitor, RYTELO (imetelstat) for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes (lower-risk MDS), with transfusion-dependent (TD) anemia requiring four or more red blood cell units over eight weeks who have not responded to or have lost response to or are ineligible for erythropoiesis-stimulating agents (ESAs). RYTELO is supported by the high unmet need in lower-risk MDS, including the observed benefit of RYTELO in difficult-to-treat subpopulations, such as patients with high transfusion burden and ring sideroblast negative (RS-) patients. It is also engaged in conducting a pivotal Phase III clinical trial of imetelstat in JAK-inhibitor relapsed/refractory myelofibrosis (R/R MF), as well as studies in other myeloid hematologic malignancies.
Find out what a historical investment in Geron Corporation would be worth today using our GERN stock calculator.
Market Capitalisation
$782.66M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
8.38M
High today
$1.28
Low today
$1.23
Open price
$1.24
52-week high
$2.01
52-week low
$1.04
Ready to start your investing journey with Stake?
Open an accountHow do I buy GERN shares in Australia?
Buying GERN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Geron Corporation in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in GERN
What is the ticker symbol of Geron Corporation?
The ticker symbol for Geron Corporation is GERN.
How much is one share of GERN?
One share of GERN is valued at $1.27 as of 20 May 2026.
What is the market capitalisation of Geron Corporation GERN?
As of 20 May 2026 Geron Corporation has a market cap of $782.66M.
What is the 52-week high for Geron Corporation stock?
The Geron Corporation 52-week high stock price is $2.01.
What is the 52-week low for Geron Corporation stock?
The Geron Corporation 52-week low stock price is $1.04.
Can I buy GERN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy GERN shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in GERN on Stake
- Buy GERN from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of GERN from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
GERN related stocks